» Articles » PMID: 37508544

Roles of Extracellular Vesicles on the Progression and Metastasis of Hepatocellular Carcinoma

Overview
Journal Cells
Publisher MDPI
Date 2023 Jul 29
PMID 37508544
Authors
Affiliations
Soon will be listed here.
Abstract

Liver cancer is a global health challenge as it is the third leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) is the most common type of liver cancer and is often found in liver cells, where it is associated with high morbidity and mortality rates. Recent studies have shown that extracellular vesicles (EVs) secreted by HCC cells play a critical role in HCC progression and metastasis. EVs contain proteins, nucleic acids, lipids, and metabolites as cargos. EVs derived from HCC cells can transfer oncogenic factors to surrounding cells leading to increased tumor growth, cell invasion, and angiogenesis. In this review, we summarize the roles that EVs play and the specific effects of their cargos on HCC progression and metastasis and identify potential therapeutic targets for HCC treatment.

Citing Articles

Disorders: Basics of Biology and Therapeutics in Development.

Gillett D, Tigro H, Wang Y, Suo Z Cells. 2025; 13(24.

PMID: 39768191 PMC: 11674747. DOI: 10.3390/cells13242100.


Point-of-care testing for early-stage liver cancer diagnosis and personalized medicine: Biomarkers, current technologies and perspectives.

Liu M, Wen Y Heliyon. 2024; 10(19):e38444.

PMID: 39397977 PMC: 11470528. DOI: 10.1016/j.heliyon.2024.e38444.


Molecular Mechanisms in Tumorigenesis of Hepatocellular Carcinoma and in Target Treatments-An Overview.

Szilveszter R, Muntean M, Florea A Biomolecules. 2024; 14(6).

PMID: 38927059 PMC: 11201617. DOI: 10.3390/biom14060656.


Unveiling the Potential of Extracellular Vesicles as Biomarkers and Therapeutic Nanotools for Gastrointestinal Diseases.

Arre V, Mastrogiacomo R, Balestra F, Serino G, Viti F, Rizzi F Pharmaceutics. 2024; 16(4).

PMID: 38675228 PMC: 11055174. DOI: 10.3390/pharmaceutics16040567.


Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics.

Papadakos S, Arvanitakis K, Stergiou I, Vallilas C, Sougioultzis S, Germanidis G Pharmaceutics. 2023; 15(10).

PMID: 37896221 PMC: 10610499. DOI: 10.3390/pharmaceutics15102460.

References
1.
Kishta S, Tabll A, Kolaric T, Smolic R, Smolic M . Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals. Biomedicines. 2020; 8(6). PMC: 7344618. DOI: 10.3390/biomedicines8060175. View

2.
Platko K, Haas-Neill S, Aziz T, Al-Nedawi K . The role of circulating extracellular vesicles in breast cancer classification and molecular subtyping. Breast J. 2019; 25(4):691-695. DOI: 10.1111/tbj.13309. View

3.
Zhu W, Li H, Yu Y, Chen J, Chen X, Ren F . Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients. Cancer Manag Res. 2018; 10:5735-5745. PMC: 6245378. DOI: 10.2147/CMAR.S182183. View

4.
Pan B, Johnstone R . Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983; 33(3):967-78. DOI: 10.1016/0092-8674(83)90040-5. View

5.
Kanwal F, Kramer J, Asch S, Chayanupatkul M, Cao Y, El-Serag H . Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents. Gastroenterology. 2017; 153(4):996-1005.e1. DOI: 10.1053/j.gastro.2017.06.012. View